Healthcare operations developer symplr acquires communications platform Halo Health mobihealthnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from mobihealthnews.com Daily Mail and Mail on Sunday newspapers.
Large Remdesivir Study Finds No COVID-19 Survival Benefit
July 16, 2021 A lack of consensus regarding the antiviral drug remdesivir to treat people with COVID-19 continues, leaving doctors without clear direction on one of the few treatments for the illness the FDA has granted emergency use authorization.
The latest research comes from Michael Ohl, MD, and colleagues who studied a large group of Veterans Administration patients hospitalized with COVID-19. Compared with a matched group of veterans who did not receive the antiviral, remdesivir did not significantly improve survival rates
The percentages were close: 12.2% of patients in the remdesivir group died within 30 days compared to 10.6% of those in the control group.
Large Remdesivir Study Finds No COVID-19 Survival Benefit medscape.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medscape.com Daily Mail and Mail on Sunday newspapers.
Finance directors.
The time participants had spent in executive roles varied from a few months to 27 years; all except one had attended Schwartz Rounds and most had attended more than once. We conducted qualitative, semi-structured interviews face-to-face or by telephone; these were transcribed and the results anonymised, before the data was sent to be analysed thematically.
Findings
Most senior leaders made a point of attending Schwartz Rounds – either as participants or as panellists who share their story – to:
Show their support;
Set an example or role model.
Several described their attendance as sending a message to the organisation that Schwartz Rounds were important and valued by the senior team, and that members of staff were being listened to. Some of their comments are used in the following discussion.
Discussion Digital Edition: Why safe and effective nurse staffing is more than just a number
08 February, 2021 Summarising a speech made at the recent Nursing Times Workforce Summit and Awards, this article explores the impact of nurse staffing levels on patient outcomes and staff burnout No online subscription: This article requires a subscription to view the full text
Subscribe for unlimited access
A personal e-Portfolio to store and save CPD and revalidation evidence
Online learning units on fundamental aspects of nursing care
Nursing news and analysis and customised email alert
Bite-size learning through NT Self-assessment and NT Journal club
Access to the Nursing Times digital archive